Impel NeuroPharma doses first patient in Phase lll trial of INP104
Impel NeuroPharma has dosed the first patient in the Phase lll Safety and Tolerability of...
Impel NeuroPharma has dosed the first patient in the Phase lll Safety and Tolerability of...